Market revenue in 2024 | USD 17.4 million |
Market revenue in 2030 | USD 49.1 million |
Growth rate | 19% (CAGR from 2025 to 2030) |
Largest segment | Pre-commercial/ r&d scale |
Fastest growing segment | Commercial Scale |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pre-commercial/ R&D Scale, Commercial Scale |
Key market players worldwide | Miltenyi Biotec, Lonza Group Ltd, Fresenius SE & Co KGaA, Cytiva, Terumo Corp, Sartorius AG, ThermoGenesis Holdings Inc, Thermo Fisher Scientific Inc, Biospherix, Cellares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to automated and closed cell therapy processing systems market will help companies and investors design strategic landscapes.
Pre-commercial/ r&d scale was the largest segment with a revenue share of 88.51% in 2024. Horizon Databook has segmented the Latin America automated and closed cell therapy processing systems market based on pre-commercial/ r&d scale, commercial scale covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America automated & closed-cell therapy processing systems market has exhibited significant growth in the past few years owing to the increased prevalence of cancer in the region. In Latin America and the Caribbean, more than 670,000 cancer deaths were reported in 2018.
Stem cell research is attracting many countries in Latin America. Several countries in Latin America have defined regenerative medicine as a research preference and focus of the investment. In Latin America, Brazil is anticipated to witness significant market growth in the market due to strong government support.
The Brazilian government has taken various initiatives to increase stem cell therapy research and development. Key initiatives include the Biosafety Act, which permits scientists to work with human embryonic stem cells, a national cell therapy network and the making of various cell technology centers to cultivate cells under GMP guidelines.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America automated and closed cell therapy processing systems market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America automated and closed cell therapy processing systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account